Board Meeting23 Mar 2026, 12:46 pm
Bal Pharma Ltd Closes Trading Window for Q4 FY 2025-2026
AI Summary
Bal Pharma Ltd has announced the closure of the trading window for dealing with the securities of the company for the quarter and financial year ended 31/03/2026. The closure is in accordance with the company's code of conduct and the amended provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed from 18th April 2026 and will remain closed until 48 hours after the declaration of the audited financial results. The date of the board meeting for the declaration of the audited financial results is yet to be intimated to the exchange.
Key Highlights
- Bal Pharma Ltd has closed the trading window for dealing with the company's securities.
- The closure is in accordance with the company's code of conduct and SEBI regulations.
- The trading window will remain closed from 18th April 2026 until 48 hours after the declaration of the audited financial results.
- The date of the board meeting for the declaration of the audited financial results is yet to be announced.
Price Impact
More from BALPHARMA